These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 2512230

  • 1. [GM-CSF: target cells and their response kinetics].
    Aglietta M, Piacibello W, Aprá F, Stacchini A, Sanavio F, Monzeglio C, Mossetti C, Bussolino F, Gavosto G.
    Haematologica; 1989 Oct; 74(5 Suppl):478-88. PubMed ID: 2512230
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Human recombinant granulocyte-macrophage colony stimulating factor and interleukin 3 have overlapping but distinct hematopoietic activities.
    Emerson SG, Yang YC, Clark SC, Long MW.
    J Clin Invest; 1988 Oct; 82(4):1282-7. PubMed ID: 3049674
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combinations of purified recombinant colony-stimulating factors are required for optimal hematopoietic differentiation.
    Sieff CA, Ekern S, Nathan DG.
    Trans Assoc Am Physicians; 1988 Oct; 101():282-7. PubMed ID: 2480018
    [No Abstract] [Full Text] [Related]

  • 8. An in vitro model for the production of committed haemopoietic progenitor cells stimulated by exposure to single and combined recombinant growth factors.
    Gordon MY, Clarke D, Healy LE.
    Bone Marrow Transplant; 1989 Jul; 4(4):353-8. PubMed ID: 2673454
    [Abstract] [Full Text] [Related]

  • 9. Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate.
    Bussolino F, Wang JM, Defilippi P, Turrini F, Sanavio F, Edgell CJ, Aglietta M, Arese P, Mantovani A.
    Nature; 1989 Feb 02; 337(6206):471-3. PubMed ID: 2464767
    [Abstract] [Full Text] [Related]

  • 10. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
    Santiago-Schwarz F, Rappa DA, Laky K, Carsons SE.
    Stem Cells; 1995 Mar 02; 13(2):186-97. PubMed ID: 7540472
    [Abstract] [Full Text] [Related]

  • 11. Effects of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) on single CD34-positive hemopoietic progenitors from human bone marrow.
    Mayani H, Baines P, Jones A, Hoy T, Jacobs A.
    Int J Cell Cloning; 1989 Jan 02; 7(1):30-6. PubMed ID: 2645375
    [Abstract] [Full Text] [Related]

  • 12. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE, Cooper S, Williams DE, Hangoc G, Gutterman JU, Vadhan-Raj S.
    Exp Hematol; 1988 Aug 02; 16(7):594-602. PubMed ID: 3260558
    [Abstract] [Full Text] [Related]

  • 13. Kinetic response of human marrow myeloid progenitor cells to in vivo treatment of patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE, Benninger L, Patel SR, Benjamin RS, Vadhan-Raj S.
    Exp Hematol; 1994 Jan 02; 22(1):100-2. PubMed ID: 7506671
    [Abstract] [Full Text] [Related]

  • 14. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Rizzoli V.
    Stem Cells; 1993 Jul 02; 11 Suppl 2():170-4. PubMed ID: 7691323
    [Abstract] [Full Text] [Related]

  • 15. Interaction of transforming growth factor-beta 1 with hemopoietic growth factors in the regulation of human normal and leukemic myelopoiesis.
    Aglietta M, Stacchini A, Severino A, Sanavio F, Ferrando ML, Piacibello W.
    Exp Hematol; 1989 Mar 02; 17(3):296-9. PubMed ID: 2783914
    [Abstract] [Full Text] [Related]

  • 16. Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor.
    Aglietta M, Piacibello W, Sanavio F, Stacchini A, Aprá F, Schena M, Mossetti C, Carnino F, Caligaris-Cappio F, Gavosto F.
    J Clin Invest; 1989 Feb 02; 83(2):551-7. PubMed ID: 2643633
    [Abstract] [Full Text] [Related]

  • 17. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C, Regazzi E, Andrizzi C, Savoldo B, Garau D, Montefusco E, Vignetti M, Mandelli F, Rizzoli V, Meloni G.
    Haematologica; 1997 Feb 02; 82(3):291-6. PubMed ID: 9234574
    [Abstract] [Full Text] [Related]

  • 18. The effect of human recombinant GM-CSF on the myelopoiesis in a long-term bone marrow culture (LTBMC).
    Haas R, Kiesel S, Ogniben E, Baumann M, Hohaus S, Körbling M, Dörken B, Hunstein W.
    Behring Inst Mitt; 1988 Aug 02; (83):278-83. PubMed ID: 3071341
    [Abstract] [Full Text] [Related]

  • 19. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM, Gulati SC.
    Stem Cells; 1993 Sep 02; 11(5):435-44. PubMed ID: 7694721
    [Abstract] [Full Text] [Related]

  • 20. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on the hemopoietic progenitor cells from patients with AIDS.
    Ganser A, Völkers B, Greher J, Hoelzer D.
    Behring Inst Mitt; 1988 Aug 02; (83):284-8. PubMed ID: 3071342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.